ArticleClinicoEconomics and outcomes research : CEOR2012

Budget impact analysis of boceprevir and telaprevir for the treatment of hepatitis C genotype 1 infection.

Kristian Thorlund et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.